The performance of companies tied to Sildenafil's legacy presents a challenging investment scenario . While the initial success generated substantial profits , generic copies have significantly diminished https://leftbookmarks.com/story21686282/copyright-s-flagship-product-and-big-pharma-a-speculative-opportunity